Such-Lupe

International sales activities

Bosnia-Herzegovina

In Bosnia-Herzegovina sales in local currency declined by 22% in financial year 2009; in euro, sales also decreased by 22% to EUR 14.8 million in the financial year 2009 (previous year: EUR 19.0 million). The focus of local business activities continues to be on the Serbian-oriented part of the country. In the financial year 2009, STADA raised its stake in existing majority shareholdings of Cajavec sistemi upravljanja A.D., Bosnia-Herzegovina, by an increase of the stake of the STADA subsidiary Hemofarm from the previous 96.78% to the current 97.70%. Cajavec sistemi upravljanja is currently non-operational.

Sales decreased in the first three months of 2010 applying last year’s exchange rates by 63%. In Euro sales decreased by 65% to EUR 3.5 million (1-3/2009: EUR 9.9 million).

Bosnia-Herzegovina - Sales by segments in EUR million

1) Sales below EUR 0.05 million were rounded to EUR 0.0 million.

Bosnia-Herzegovina - Sales by segments in EUR million

STADA sales activities: Bosnia-Herzegovina
Here you will find corporate news and ad-hoc releases that you can read directly on your screen or download as a PDF file. Older releases are available for you in our archive. More
The current STADA share price with share price chart including Excel download and market capitalization of STADA Arzneimittel AG are available here. We also offer you an interactive peer group share price comparison. More
Here you will find photos (available in two resolutions) of the STADA Executive Board, buildings, flags and STADA Arzneimittel AG production facilities, which you may download in unchanged form for your press work. More

 

(c) 2010 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de